NEW YORK – What were the articles that gained the most interest from GenomeWeb readers last week? Here are the top five:
- FDA Will No Longer Review EUA Submissions for SARS-CoV-2 Lab-Developed Tests
- 10x Genomics to Acquire ReadCoor for $350M, Cartana for $41.2M
- Unique COVID-19 Phenotype Emerges Through Multi-Omic Patient Analysis
- Guardant Health Liquid Biopsy Test Improves Gastrointestinal Cancer Clinical Trial Enrollment
- Invitae Completes Acquisition of ArcherDx